AmerisourceBergen Corporation (ABG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, AmerisourceBergen Corporation (ABG) has a cash flow conversion efficiency ratio of -1.100x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.31 Billion) by net assets (€2.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
AmerisourceBergen Corporation - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how AmerisourceBergen Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
AmerisourceBergen Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AmerisourceBergen Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AutoZone Inc
NYSE:AZO
|
-0.292x |
|
Baker Hughes Co
NASDAQ:BKR
|
0.087x |
|
Aflac Incorporated
NYSE:AFL
|
0.042x |
|
Sempra
SA:S1RE34
|
0.047x |
|
Lloyds Banking Group plc
F:LLD2
|
N/A |
|
Nu Holdings Ltd
NYSE:NU
|
0.221x |
|
APOLLO GL.M.NEW DL-00001
F:N7I
|
N/A |
|
Wesfarmers Ltd
AU:WES
|
0.317x |
Annual Cash Flow Conversion Efficiency for AmerisourceBergen Corporation (2019–2025)
The table below shows the annual cash flow conversion efficiency of AmerisourceBergen Corporation from 2019 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €1.75 Billion | €3.88 Billion | 2.218x | -49.92% |
| 2024-09-30 | €786.74 Million | €3.48 Billion | 4.429x | -24.55% |
| 2023-09-30 | €666.29 Million | €3.91 Billion | 5.870x | -84.52% |
| 2022-09-30 | €71.27 Million | €2.70 Billion | 37.926x | +731.19% |
| 2021-09-30 | €584.41 Million | €2.67 Billion | 4.563x | +273.59% |
| 2020-09-30 | €-839.64 Million | €2.21 Billion | -2.629x | -435.66% |
| 2019-09-30 | €2.99 Billion | €2.34 Billion | 0.783x | -- |
About AmerisourceBergen Corporation
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical cli… Read more